Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PRAD | rs150701428 | chr11:36308798 | T/C | 0.000103 | 477 | 30.53 | 32.45 | 27.57 | KM Plot |
PRAD | rs150714696 | chr15:64432001 | A/G | 9.69E-6 | 490 | 31.27 | 27.47 | 42.67 | KM Plot |
PRAD | rs150733650 | chr22:21358919 | CCTGA/C | 8.7E-5 | 476 | 31.27 | 28.43 | 30.4 | KM Plot |
PRAD | rs150863768 | chr9:72851320 | C/T | 1.73E-5 | 493 | 30.8 | 31.35 | 22.45 | KM Plot |
PRAD | rs150873 | chr7:73606190 | A/G | 6.67E-5 | 489 | 24.83 | 28.43 | 31.37 | KM Plot |
PRAD | rs150883593 | chr2:107440921 | T/G | 3.36E-5 | 492 | 30.97 | 30.53 | 32.63 | KM Plot |
PRAD | rs151096062 | chr1:201129749 | AT/A | 2.22E-11 | 479 | 43.53 | 30.87 | 30.9 | KM Plot |
PRAD | rs151243268 | chr1:93731458 | CA/C | 3.77E-6 | 492 | 31.37 | 26.8 | 18.97 | KM Plot |
PRAD | rs1529083 | chr7:154941814 | G/A | 2.95E-6 | 484 | 30.8 | 31.13 | 37.42 | KM Plot |
PRAD | rs1530719 | chr2:129056518 | G/A | 3.53E-5 | 475 | 31.27 | 29.17 | 31.43 | KM Plot |
PRAD | rs1532858 | chr1:31762374 | C/T | 1.82E-6 | 493 | 22.85 | 31.25 | 31.27 | KM Plot |
PRAD | rs1545246 | chr15:99974743 | A/G | 9.63E-7 | 494 | 61.83 | 26.1 | 31.37 | KM Plot |
PRAD | rs1587381 | chr15:76769620 | G/A | 8.02E-5 | 494 | 28.3 | 31.87 | 30.87 | KM Plot |
PRAD | rs1589113 | chr1:169270744 | C/T | 2.68E-5 | 494 | 21.2 | 29.4 | 31.27 | KM Plot |
PRAD | rs15968 | chr17:37819335 | C/G | 5.4E-6 | 493 | 30.8 | 33.05 | 28.63 | KM Plot |